Rezultati pretraživanja
  1. prije 3 sata
  2. prije 5 sati

    Stocks to Watch for February 6, 2020 for , , , , , , , and is now posted in our Stocks To Watch Channel and at

  3. prije 7 sati
  4. prije 8 sati

    sneaking around

  5. continues with high-affinity NY-ESO-1 from as an Adaptimmune SPEAR T-cell therapy and as bispecific with sister-company

  6. 4. velj

    Top 5 Performing Breakout Stocks within the last Month

  7. 4. velj

    -Responses in 5(!)solid tumor indications-Plan to launch first product in 2022 -Agreement w/Astellas to co-develop/co-commercialize T-Cell therapies(may receive up to $900M)Plenty of clinical catalysts in2020-ADP-A2AFP data update-Safety&response data from SURPASS -SPEARHEAD

  8. 4. velj
  9. 3. velj

    is moving up....!

  10. 3. velj

    Does look ready to run!!!

  11. 3. velj

    Cell therapy is One of the Hottest biotech sectors! It's time to go up!

  12. 31. sij
  13. 30. sij

    has an excellent technical rating and also presents a decent setup pattern. ...

  14. 30. sij

    Recent trades = +$620 (01/13/20) = -$18 (01/17/20) = +$400 (01/22/20) Started taking small positions to manage risk. Results are better than before.

  15. 30. sij

    big buys 👀

  16. 29. sij
  17. 29. sij

    Bought 4000 shares at 4.04

  18. 29. sij

    Adaptimmune Therapeutics PLC – Major Shareholder Peter W. Sonsini Acquires 7,500,000 Shares

  19. 28. sij

    : ARE YOU READY TO MISS THE NEXT , , , OR ? 💫THIS IS A INDUSTRY DISRUPTOR WORTH LOOKING INTO AND AT 5 YEAR LOWS

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.